Try our beta test site
101 studies found for:    Open Studies | "Dry Eye Syndromes"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Recruiting Assessment of the Safety and Efficacy of RGN-259 Ophthalmic Solutions for Dry Eye Syndrome : ARISE-2
Condition: Dry Eye Syndrome
Interventions: Drug: RGN-259;   Drug: Placebo
2 Recruiting Effect of Nursing Care on Prevention of Dry Eye
Condition: Dry Eye Syndromes
Interventions: Device: LACRIBELL®;   Device: VIDISIC® GEL
3 Recruiting Topical Ophthalmic AGN-195263 for the Treatment of Evaporative Dry Eye
Condition: Dry Eye Syndromes
Interventions: Drug: AGN-195263;   Drug: Vehicle
4 Recruiting Topical Ophthalmic AGN-195263 for the Treatment of Evaporative Dry Eye
Condition: Dry Eye Syndromes
Interventions: Drug: AGN-195263;   Drug: Vehicle
5 Recruiting Safety and Efficacy of TOP1630 for Dry Eye Syndrome
Condition: Dry Eye Syndrome
Interventions: Drug: TOP1630 Ophthalmic Solution;   Drug: Placebo to TOP1630 Ophthalmic Solution
6 Recruiting Efficacy and Safety Study of HU00701/HU007 Eye Drops in Patients With Dry Eye Syndrome
Condition: Dry Eye Syndrome
Interventions: Drug: HU00701;   Drug: HU007;   Drug: Restasis;   Drug: Placebo
7 Not yet recruiting Safety and Efficacy of BRM421 for Dry Eye Syndrome
Condition: Dry Eye Syndrome
Intervention: Drug: BRM421
8 Not yet recruiting Efficacy Comparison of Two Kinds of Treatment in Treating Dry Eye Caused by Meibomian Gland Dysfunction
Condition: Dry Eye Syndrome
Interventions: Device: intense pulsed light;   Drug: Tobramycin and Dexamethasone Ophthalmic Ointment
9 Not yet recruiting Effect of Benzalkonium Chloride Containing Eye Drops on the Conjunctival Bacterial Flora of Dry Eye Patients
Condition: Dry Eye Syndromes
Interventions: Drug: Prosicca;   Drug: Prosicca sine;   Other: Bacterial culture
10 Not yet recruiting A Two Comparator, Controlled Phase 3 Study in Patients With and Without Evaporative Dry Eye
Condition: Dry Eye Syndromes
Interventions: Drug: Omega 3;   Drug: Optive Advanced;   Drug: Optive
11 Recruiting Comparison of the Clinical Effects of Two Tear Substitutes in Patients With Dry Eye Syndrome
Condition: Dry Eye
Interventions: Drug: Liposic;   Drug: Tears Naturale Forte
12 Recruiting Lamelleye vs Comparator for the Treatment of Dry Eye Disease
Condition: Dry Eye Syndromes
Interventions: Device: Lamelleye Dry Eye Drops;   Device: Optive Plus
13 Recruiting DNase Treatment for Dry Eyes
Condition: Dry Eye
Interventions: Drug: DNase;   Drug: Vehicle
14 Recruiting Study to Evaluate the Efficacy and Safety of CKD-350
Condition: Dry Eye Syndrome
Interventions: Drug: Xenobella;   Drug: Isotonic 0.3% Sodium Hyaluronate
15 Recruiting 0.3% Sodium Hyaluronate in the Treatment of Dry Eye of Diabetic Patients
Conditions: Dry Eye Syndromes;   Diabetes Mellitus
Intervention: Drug: 0.3% Sodium Hyaluronate
16 Recruiting Evaluation of Dry Eye by Tear Film Imager in a Low Humidity Environmental Exposure Chamber (TFI-LH16)
Condition: Dry Eye
Interventions: Diagnostic Test: Tear Film Imager;   Diagnostic Test: Low Humidity Environmental Exposure Chamber (LH-EEC)
17 Recruiting Safety and Efficacy of KPI-12 in Subjects With Dry Eye Disease
Conditions: Dry Eye Syndromes;   Keratoconjunctivitis Sicca
Interventions: Drug: KPI-121 0.25% Ophthalmic Suspension;   Drug: Vehicle of KPI-121 0.25% Ophthalmic Suspension
18 Recruiting Safety and Efficacy of KPI-121 Compared to Placebo in Subjects With Dry Eye Disease
Conditions: Dry Eye Syndromes;   Keratoconjunctivitis Sicca
Interventions: Drug: KPI-121 0.25% Ophthalmic Suspension;   Drug: Vehicle of KPI-121 0.25% Ophthalmic Suspension
19 Recruiting Can Pregabalin Reduce the Frequency and Severity of Dry Eye Symptoms After Laser-assisted in Situ Keratomileusis?
Condition: Dry Eye
Interventions: Drug: Pregabalin;   Drug: Placebo
20 Recruiting Dry Eye Assessment and Management Study
Condition: Dry Eye
Interventions: Drug: Omega-3 supplements;   Drug: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.